Clinical trial
Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension…
NCT00034840 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00034840 |
|---|---|
| Title | Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose |
| Official title | A Prospective, Randomized, Double-Blind, Forced Titration Trial to Compare the Efficacy of MICARDIS® (Telmisartan 80 mg p.o. Once Daily) and Diovan® (Valsartan 160 mg p.o. Once Daily) Using Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Hypertension After Missing One… |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Collaborators | GlaxoSmithKline Industry Bayer |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | telmisartan, valsartan |
| Enrollment | 490 |
| Start date | Oct 1, 2001 |
| Primary completion | Aug 1, 2002 |
| Completion | Aug 1, 2002 |
| First posted | May 3, 2002 |
| Last update posted | Nov 1, 2013 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: